FRIDAY, Dec. 3, 2021 (HealthDay News) — If you’re getting together with others outdoors, a windy day might be best, researchers say. The investigators found that when people socialize outside, the risk of coronavirus infection is as much as 45% greater when there’s hardly any breeze than when there areContinue Reading
THURSDAY, Dec. 2, 2021 (HealthDay News) — Just one day after the first Omicron case was reported in the United States, federal officials announced a second case on Thursday, this time in a Minnesota man who had traveled to an Anime convention in New York City in November. The U.S.Continue Reading
THURSDAY, Dec. 2, 2021 (HealthDay News) — Children and teenagers vaccinated against the mumps virus have accounted for one-third of infections in recent years, a new U.S. government study finds. The reasons are unclear, and experts stressed that routine childhood vaccination remains the best weapon against mumps — a contagiousContinue Reading
THURSDAY, Dec. 2, 2021 (HealthDay News) — People who recovered from a severe case of COVID-19 may have more to worry about: New research finds that patients hospitalized with COVID are 2.5 times more likely to die within the year than people who never contracted the coronavirus. They also areContinue Reading
THURSDAY, Dec. 2, 2021 (HealthDay News) — President Joe Biden plans to announce a new round of measures to protect Americans against the spread of coronavirus variants on Thursday. The strategy will include making rapid at-home COVID-19 tests free for more people, extending rules on mask wearing on planes andContinue Reading
THURSDAY, Dec. 2, 2021 (HealthDay News) — Which coronavirus vaccine is best at beating COVID-19 — Moderna or Pfizer? New research hands that honor to Moderna: In what is billed as the first head-to-head comparison of the two shots, researchers analyzed the health records of nearly 440,000 U.S. veterans whoContinue Reading
WEDNESDAY, Dec. 1, 2021 (HealthDay News) — The first confirmed U.S. case of the Omicron variant has been reported in California, the U.S. Centers for Disease Control and Prevention announced Wednesday. The patient was a traveler, apparently from the San Francisco area, who returned from South Africa on Nov. 22,Continue Reading
WEDNESDAY, Dec. 1, 2021 (HealthDay News) — With HIV a continuing threat to women’s health, the World Health Organization (WHO) has approved the first long-acting device to protect women from sexually transmitted HIV. The device is a vaginal ring made of silicone elastomer, a flexible rubber-like material that makes itContinue Reading
WEDNESDAY, Dec. 1, 2021 (HealthDay News) — They once ruled the planet, but even the mighty Tyrannosaurus rex could suffer from bone disease, new research shows. Scientists used imaging to examine the lower left jaw of a fossilized T. rex skeleton discovered in Montana in 2010. The skeleton, which isContinue Reading
TUESDAY, Nov. 30, 2021 (HealthDay News) — Americans who are vaccinated and boosted against COVID-19 should have enough antibody protection to prevent severe illness if they become infected with the new Omicron variant, White House COVID response officials said Tuesday. Omicron has caused concern among medical experts due to aContinue Reading
TUESDAY, Nov. 30, 2021 (HealthDay News) — The often debilitating condition known as chronic fatigue syndrome appears to be common among COVID-19 long-haulers. That’s the key takeaway from a fresh look at patients who continue to struggle with severe fatigue, poor sleep, brain fog, muscle aches and pains long afterContinue Reading
TUESDAY, Nov. 30, 2021 (HealthDay News) — A U.S. Food and Drug Administration advisory panel on Tuesday voted narrowly to recommend emergency use of Merck’s new antiviral pill to help prevent severe COVID-19 in high-risk patients. By a 13-10 count, the panelists recommended molnupiravir for use by older COVID-19 patientsContinue Reading
TUESDAY, Nov. 30, 2021 (HealthDay News) — The first wave of girls to receive the HPV vaccine are much less likely to contract or die from cervical cancer than women just a few years older, a new study reports. Nearly all cases of cervical cancer are caused by human papillomavirusContinue Reading
TUESDAY, Nov. 30, 2021 (HealthDay News) — Regeneron Pharmaceuticals said Tuesday that its antibody cocktail, which is used widely to treat COVID-19 patients, may be less effective against the Omicron variant. The company noted that prior analyses suggest that its monoclonal antibody cocktail, and similar drugs, could lose effectiveness againstContinue Reading